Increased expression of interleukin-6 gene in gastritis and gastric cancer

Abstract

Helicobacter pylori (H. pylori) induces an intense inflammatory response, mediated by proinflammatory cytokines, including interleukin (IL)-6 and its membrane receptor (IL-6R), which activates important signaling pathways in the development of gastric disease and cancer. We investigated the gene and protein expression of IL-6 and IL-6R and the influence of polymorphisms rs1800795, rs1800796, and rs1800797 on its gene expression together with H. pylori infection. Furthermore, an in-silico analysis was performed to support our results. Gastric biopsies were obtained from patients with gastric symptoms and patients with gastric cancer (GC) and were divided into groups (Control, Gastritis, and Cancer). H. pylori was detected by PCR. Realtime-qPCR was employed to determine gene expression, and western blot assay was used to analyze protein expression levels. PCR-RFLP was used to characterize IL-6 polymorphisms. Bioinformatics analyses were performed using the Gene Expression Omnibus (GEO) database and GEO2R to screen out differentially expressed genes (DEGs). H. pylori was detected in 43.3% of the samples. Statistically significant differences were found for IL-6 (P=0.0001) and IL-6R (P=0.0005) genes among the three groups, regardless of the presence of H. pylori. Among patients with H. pylori infection, the IL-6 and IL-6R gene and protein expressions were significantly increased, highlighting IL-6 gene overexpression in patients with GC. No statistically significant differences were found for the rs1800795, rs1800796, and rs1800797 polymorphisms compared to IL-6 gene expression. The results indicated that the IL-6 polymorphisms do not influence its expression, but IL-6 and IL-6R expression seems to be altered by the presence of H. pylori.

Mitigation of Gastric Damage Using Cinnamomum cassia Extract: Network Pharmacological Analysis of Active Compounds and Protection Effects in Rats

“…Furthermore, these genes are also important in controlling gastritis. Helicobacter pylori ( H. pylori ), one of the causes of gastritis, induces inflammatory responses mediated by pro-inflammatory cytokines, such as IL6 [ 26 ]. Moreover, the expression levels of TNF, IL1B, and CXCL8 increase in the gastric mucosa during a H. pylori infection [ 27 , 28 ].…”

Basic Traditional Chinese Medicinal Compound for Adjuvant Treatment of Helicobacter pylori-Related Gastritis: Implication for Anti-H. pylori-Related Gastritis Drug Discovery

“…The expression of IL-6 and its receptor was significantly increased in patients infected with H. pylori , especially in those with gastric cancer. 83 As a cytokine that can be synthesized and secreted by normal cells and tumor cells, VEGF is expressed at low levels in normal tissue cells at a relatively constant expression level, but its expression is upregulated in many tumor cells and is the most important regulator to promote tumor cell neogenesis. VEGFA, a member of the VEGF family that is closely related to angiogenesis, can activate VEGFR2, a receptor on endothelial cells, and promote the formation of new blood vessels and tumor cell migration.…”

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far

“…Upon infection with H. pylori , the epithelial cells of the stomach release ROS, nitric oxide, and chemokines that triggered the production of proinflammatory cytokines, such as interleukin-8 (IL-8), which have been identified as effectors of the inflammatory role in the induction and promotion of the oncogenic process(es) ( 53 , 54 ). There is also release of interleukin-6 (IL-6), an anti-apoptotic factor, which plays a crucial role in triggering critical signaling pathways, including the activation of JAK, STAT3, PI3K, MAPK, and AMPK ultimately leading to inflammation ( 55 ). H. pylori induce the Signal Transducer and Activator of Transcription 3 (STAT3) protein activation via ROS generation leading to increased expression of the interleukins -6 (IL-6) and -11 (IL-11) ( 56 , 57 ).…”